Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 13, 2025
Accession Number:
0001628280-25-011345
Submission Type:
POS AM
CIK:
0001636282
Company Name:
Spyre Therapeutics, Inc.
File Number:
333-281975